title: L-carnitine: a way to decrease cellular toxicity of ifosfamide?
authors.forename: J S
authors.initials: JS
authors.lastname: Schlenzig
authors.forename: C
authors.initials: C
authors.lastname: Charpentier
authors.forename: D
authors.initials: D
authors.lastname: Rabier
authors.forename: P
authors.initials: P
authors.lastname: Kamoun
authors.forename: A C
authors.initials: AC
authors.lastname: Sewell
authors.forename: J P
authors.initials: JP
authors.lastname: Harpey
mesh_terms: D000818:Animals; D002331:Carnitine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005977:Glutarates / Q000652:urine*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects* / Q000627:therapeutic use; D007274:Injections, Intraperitoneal; D051381:Rats; D017208:Rats, Wistar
chemical_list: D005977:Glutarates; C035736:glutaric acid; D002331:Carnitine; D007069:Ifosfamide